Presenter: James McCormack BSc (Pharm) Pharm D Mike Allan MD Mike Kolber MD
0:00
In episode 442, James and Mike welcome back Mike Kolber to discuss all the evidence around biosimilars. The issue is exactly the same one we have had for decades with the question around brand name versus generic medications. Tune in and find out the answer. At the conclusion of this activity, participants will be able…
This content is for *CFPC Member Rate, CFPC Member Rate, Non-CFPC Member Rate, and Resident members only.
Login Join Now
Login Join Now
Latest Podcasts
BS Medicine Episode #539: You have prostate cancer – now what?
In episode 539, James and Mike focus in a PREMIUM way on the latest prostate cancer intervention trial. Patients with prostate cancer were randomized to active monitoring, surgery, or radiotherapy…
BS Medicine Episode #538: Egging you on to look at the evidence around eggs
In episode 538, James and Mike discuss the great (but pretty much silly) egg controversy. We go over the best available evidence for eggs which is at best not great.…
BS Medicine Episode #537: A Jab for Your CAD: Influenza vaccination for the prevention of cardiovascular events
In episode 537, Mike and James invite Ricky Turgeon back to the podcast to talk about the impact of the influenza vaccination on cardiovascular events in both primary and secondary…
May 26, 2021
Presenter(s):
James McCormack BSc (Pharm) Pharm D Mike Allan MD Mike Kolber MD
Please provide any additional comments (optional).